PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4257

  1. 5,236 Posts.
    lightbulb Created with Sketch. 677
    Totally agree and have said the same thing for a long time. Given the market size and nothing that treats OA, the data just can’t be as good as we are all lead to believe. Any mob would be able to do a deal with par for f* all given their cash position so even more reason to doubt it. Daniel Tillett reckons the sweet spot for a deal is after phase 2 so imagine how shit the deal will be if we do get 1 anyway?? Also, more intelligent people than me say that if a company gets to revenue they are doing something wrong bcos it means nobody has wanted it.
    Touching on what Simon said to my mate at work, he also told me a few things that were going to happen 18 months ago that I’m still waiting to happen. Let’s hope this is 1 that he doesn’t talk shit about but until it happens I’m doubtful.




 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.